MSB - update on their Covid ARDS trial results today. Good results from the under 65s and overall quite positive. Still need to analyse their secondary endpoints. Seem confident with Novartis and should have an announcement on that deal in May. Closing the deal should be a major catalyst so it looks like this could be the turnaround point.
